STEMBOND TECHNOLOGIES LTD
Company number 13576323 · Active · Cambridge CB1 2LA
STEMBOND TECHNOLOGIES LTD is an active private limited company (company number 13576323) incorporated on 20 August 2021, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 August 2025, showing net assets of £234k and cash of £203k, with 9 employees on average. Net assets rose 204% on the prior period (−£225k).
By net assets it sits in the upper half of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
Key dates
- Incorporated
- 20 August 2021
- Next accounts due
- 31 May 2027 — in 221 days
- Confirmation statement due
- 3 September 2027 — in 316 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- Total Exemption Full
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 31 August 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 August 2025 | £234k | £203k | — | £175k | — | — | 9 |
| 31 August 2024 | −£225k | £131k | — | £17k | — | — | 8 |
- Current ratio
- 2.18 — comfortable
- Cash per employee
- £23k
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score: 88/100 (grade A)
- +10 Positive net assets — Net assets £233,904 at 2025-08-31
- +8 Net assets growing — +204.1% vs prior period
- +8 Comfortable liquidity — Current ratio 2.18
- +4 Cash reserves — Cash £203,183
- +8 Established — Incorporated 2021-08-20 (5 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Dr Andrew Christopher Hodgson — owns 25–50% of shares; holds 25–50% of voting rights; can appoint or remove directors · since 20 August 2021
- Dr Kevin James Chalut — owns 25–50% of shares; holds 25–50% of voting rights; can appoint or remove directors · since 20 August 2021 · ceased 31 May 2022
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in Cambridge
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- ACCIO TX BIOBANK ONLINE LTD — Newmarket, inc. Aug 2021
- ACCIO V BIOBANK ONLINE LTD — Newmarket, inc. Aug 2021
- BLOOMSBURY GENETIC THERAPIES LIMITED — Waterbeach, inc. Aug 2021
- PODIUM BIO LIMITED — Cambridge, inc. Jul 2021
- NEW ROAD THERAPEUTICS LIMITED — Cambridge, inc. Oct 2021
- AILA BIOTECH LTD — Cambridge, inc. Oct 2021
All companies incorporated on 20 August 2021 · in Aug 2021.
Reminders for STEMBOND TECHNOLOGIES LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.